F. Ruiz et al., POTENTIATION OF ACUTE OPIOID-INDUCED RESPIRATORY DEPRESSION AND REVERSAL OF TOLERANCE BY THE CALCIUM-ANTAGONIST NIMODIPINE IN AWAKE RATS, Naunyn-Schmiedeberg's archives of pharmacology, 348(6), 1993, pp. 633-637
The interaction between sufentanil, a mu-opioid agonist, and the Ca2antagonist nimodipine on respiration and on the development of opioid
tolerance in awake rats has been analyzed. Our previous work demonstra
ted that chronic treatment with nimodipine together with sufentanil in
creases the analgesic potency of the opioid 50 fold. Therefore, we hav
e investigated whether the opioid-induced respiratory depression is po
tentiated in parallel with the analgesia. Ventilation was measured by
the whole body plethysmographic method. In naive rats, sufentanil (10-
80 mug/kg) consistently induced a dose-dependent respiratory depressio
n. Pretreatment with nimodipine (200 mug/kg) potentiated this effect b
ut to a lesser extent than it potentiated analgesia. After chronic adm
inistration of the opioid (2 mug/h, 7 days) tolerance was manifested a
s a reduction in both the area under the time course curve and in the
maximum effect. Nimodipine (1 mug/h) administered concurrently with su
fentanil for 7 days counteracted the tolerance to respiratory depressi
on but no additional potentiation was observed. These results demonstr
ate that the interaction between nimodipine and sufentanil is not limi
ted to antinociception but also exends to respiratory depression. Howe
ver, compared with analgesia, the clinical relevance of a potential in
crease in opioid-induced respiratory depression by nimodipine may be n
egligible.